|
1
|
Sinicrope FA: Increasing incidence of
early-onset colorectal cancer. N Engl J Med. 386:1547–1558.
2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Varki A: Trousseau's syndrome: Multiple
definitions and multiple mechanisms. Blood. 110:1723–1729.
2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Horsted F, West J and Grainge MJ: Risk of
venous thromboembolism in patients with cancer: A systematic review
and meta-analysis. PLoS Med. 9(e1001275)2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dienstmann R, Connor K and Byrne AT:
COLOSSUS Consortium. Precision therapy in RAS mutant colorectal
cancer. Gastroenterology. 158:806–811. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Connolly GC, Khorana AA, Kuderer NM,
Culakova E, Francis CW and Lyman GH: Leukocytosis, thrombosis and
early mortality in cancer patients initiating chemotherapy. Thromb
Res. 126:113–118. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Loupakis F, Pollina L, Stasi I, Ruzzo A,
Scartozzi M, Santini D, Masi G, Graziano F, Cremolini C, Rulli E,
et al: PTEN expression and KRAS mutations on primary tumors and
metastases in the prediction of benefit from cetuximab plus
irinotecan for patients with metastatic colorectal cancer. J Clin
Oncol. 27:2622–2629. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kumar A, Gautam V, Sandhu A, Rawat K,
Sharma A and Saha L: Current and emerging therapeutic approaches
for colorectal cancer: A comprehensive review. World J Gastrointest
Surg. 15:495–519. 2023.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chitkara A, Kaur N, Desai A, Mehta D,
Anamika F, Sarkar S, Gowda N, Sethi P, Thawani R and Chen EY: Risks
of hypertension and thromboembolism in patients receiving
bevacizumab with chemotherapy for colorectal cancer: A systematic
review and meta-analysis. Cancer Med. 12:21579–21591.
2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ades S, Pulluri B, Holmes CE, Lal I, Kumar
S and Littenberg B: Risk factors for venous thromboembolism in
metastatic colorectal cancer with contemporary treatment: A
SEER-Medicare analysis. Cancer Med. 11:1817–1826. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Andreyev HJ, Norman AR, Cunningham D,
Oates J, Dix BR, Iacopetta BJ, Young J, Walsh T, Ward R, Hawkins N,
et al: Kirsten ras mutations in patients with colorectal cancer:
The ‘RASCAL II’ study. Br J Cancer. 85:692–696. 2001.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Benjamin LE: Commentary on ‘KRAS mutation
status is predictive of response to cetuximab therapy in colorectal
cancer’. Cancer Res. 76:4309–4310. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Di Fiore F, Blanchard F, Charbonnier F, Le
Pessot F, Lamy A, Galais MP, Bastit L, Killian A, Sesboüé R, Tuech
JJ, et al: Clinical relevance of KRAS mutation detection in
metastatic colorectal cancer treated by Cetuximab plus
chemotherapy. Br J Cancer. 96:1166–1169. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ades S, Kumar S, Alam M, Goodwin A,
Weckstein D, Dugan M, Ashikaga T, Evans M, Verschraegen C and
Holmes CE: Tumor oncogene (KRAS) status and risk of venous
thrombosis in patients with metastatic colorectal cancer. J Thromb
Haemost. 13:998–1003. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Makrodouli E, Oikonomou E, Koc M, Andera
L, Sasazuki T, Shirasawa S and Pintzas A: BRAF and RAS oncogenes
regulate Rho GTPase pathways to mediate migration and invasion
properties in human colon cancer cells: A comparative study. Mol
Cancer. 10(118)2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Khorana AA, Ahrendt SA, Ryan CK, Francis
CW, Hruban RH, Hu YC, Hostetter G, Harvey J and Taubman MB: Tissue
factor expression, angiogenesis, and thrombosis in pancreatic
cancer. Clin Cancer Res. 13:2870–2875. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ünlü B and Versteeg HH: Effects of
tumor-expressed coagulation factors on cancer progression and
venous thrombosis: Is there a key factor? Thromb Res. 133 (Suppl
2):S76–S84. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rickles FR, Patierno S and Fernandez PM:
Tissue factor, thrombin, and cancer. Chest. 124 (Suppl 3):58S–68S.
2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Menapace LA, McCrae KR and Khorana AA:
Predictors of recurrent venous thromboembolism and bleeding on
anticoagulation. Thromb Res. 140 (Suppl 1):S93–S98. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ortega Morán L, García Alfonso P, Aguilar
Caballero I, Morón García B, Tirado Anula V, de Toro Carmena M,
Soto Alsar J, Gutiérrez Alonso N, Bringas Beranek M, Martín Jiménez
M and Muñoz Martín AJ: Incidence of venous thromboembolism in
patients with colorectal cancer according to oncogenic status. Clin
Transl Oncol. 22:2026–2031. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ewins K and Ní Ainle F: VTE risk
assessment in pregnancy. Res Pract Thromb Haemost. 4:183–192.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chang XN, Shang FM, Jiang HY, Chen C, Zhao
ZY, Deng SH, Fan J, Dong XC, Yang M, Li Y, et al:
Clinicopathological features and prognostic value of KRAS/NRAS/BRAF
mutations in colorectal cancer patients of Central China. Curr Med
Sci. 41:118–126. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang P, Soh KL, Ying Y, Liu Y, Huang X and
Huang J: Risk of VTE associated with PORTs and PICCs in cancer
patients: A systematic review and meta-analysis. Thromb Res.
213:34–42. 2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Johnson ED, Schell JC and Rodgers GM: The
D-dimer assay. Am J Hematol. 94:833–839. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Qin QX, Cheng XM, Lu LZ, Wei YF, Wang DC,
Li HH, Li GH, Liang HB, Li SY, Chen L and Liang ZJ: Biomarkers and
potential pathogenesis of colorectal cancer-related ischemic
stroke. World J Gastroenterol. 24:4950–4958. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Rak J, Milsom C, May L, Klement P and Yu
J: Tissue factor in cancer and angiogenesis: The molecular link
between genetic tumor progression, tumor neovascularization, and
cancer coagulopathy. Semin Thromb Hemost. 32:54–70. 2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Rickles FR, Shoji M and Abe K: The role of
the hemostatic system in tumor growth, metastasis, and
angiogenesis: Tissue factor is a bifunctional molecule capable of
inducing both fibrin deposition and angiogenesis in cancer. Int J
Hematol. 73:145–150. 2001.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yu JL, May L, Lhotak V, Shahrzad S,
Shirasawa S, Weitz JI, Coomber BL, Mackman N and Rak JW: Oncogenic
events regulate tissue factor expression in colorectal cancer
cells: Implications for tumor progression and angiogenesis. Blood.
105:1734–1741. 2005.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chen J, Bierhaus A, Schiekofer S, Andrassy
M, Chen B, Stern DM and Nawroth PP: Tissue factor-a receptor
involved in the control of cellular properties, including
angiogenesis. Thromb Haemost. 86:334–345. 2001.PubMed/NCBI
|
|
29
|
Ishimaru K, Hirano H, Yamahata H,
Takeshima H, Niiro M and Kuratsu J: The expression of tissue factor
correlates with proliferative ability in meningioma. Oncol Rep.
10:1133–1137. 2003.PubMed/NCBI
|
|
30
|
Magnus N, Garnier D, Meehan B, McGraw S,
Lee TH, Caron M, Bourque G, Milsom C, Jabado N, Trasler J, et al:
Tissue factor expression provokes escape from tumor dormancy and
leads to genomic alterations. Proc Natl Acad Sci USA.
111:3544–3549. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Horstman LL, Jy W, Jimenez JJ, Bidot C and
Ahn YS: New horizons in the analysis of circulating cell-derived
microparticles. Keio J Med. 53:210–230. 2004.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Falanga A, Marchetti M and Russo L: Venous
thromboembolism in the hematologic malignancies. Curr Opin Oncol.
24:702–710. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Davila M, Amirkhosravi A, Coll E, Desai H,
Robles L, Colon J, Baker CH and Francis JL: Tissue factor-bearing
microparticles derived from tumor cells: Impact on coagulation
activation. J Thromb Haemost. 6:1517–1524. 2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Riedl J, Preusser M, Nazari PM, Posch F,
Panzer S, Marosi C, Birner P, Thaler J, Brostjan C, Lötsch D, et
al: Podoplanin expression in primary brain tumors induces platelet
aggregation and increases risk of venous thromboembolism. Blood.
129:1831–1839. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Quintanilla M, Montero-Montero L, Renart J
and Martín-Villar E: Podoplanin in inflammation and cancer. Int J
Mol Sci. 20(707)2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Shao B, Wahrenbrock MG, Yao L, David T,
Coughlin SR, Xia L, Varki A and McEver RP: Carcinoma mucins trigger
reciprocal activation of platelets and neutrophils in a murine
model of Trousseau syndrome. Blood. 118:4015–4023. 2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Branchford BR and Carpenter SL: The role
of inflammation in venous thromboembolism. Front Pediatr.
6(142)2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Candido S, Tomasello BMR, Lavoro A,
Falzone L, Gattuso G and Libra M: Novel insights into epigenetic
regulation of IL6 pathway: In Silico perspective on inflammation
and cancer relationship. Int J Mol Sci. 22(10172)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Setiawan B, Budianto W, Sukarnowati TW,
Rizky D, Pangarsa EA, Santosa D, Setiabudy RD and Suharti C:
Correlation of inflammation and coagulation markers with the
incidence of deep vein thrombosis in cancer patients with high risk
of thrombosis. Int J Gen Med. 15:6215–6226. 2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
van Es N, Hisada Y, Di Nisio M, Cesarman
G, Kleinjan A, Mahé I, Otten HM, Kamphuisen PW, Berckmans RJ,
Büller HR, et al: Extracellular vesicles exposing tissue factor for
the prediction of venous thromboembolism in patients with cancer: A
prospective cohort study. Thromb Res. 166:54–59. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Boccaccio C and Medico E: Cancer and blood
coagulation. Cell Mol Life Sci. 63:1024–1027. 2006.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Milsom C and Rak J: Tissue factor and
cancer. Pathophysiol Haemost Thromb. 36:160–176. 2008.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Milsom C, Magnus N, Meehan B, Al-Nedawi K,
Garnier D and Rak J: Tissue factor and cancer stem cells: Is there
a linkage? Arterioscler Thromb Vasc Biol. 29:2005–2014.
2009.PubMed/NCBI View Article : Google Scholar
|
